Introduction A novel approach of ion mobility tandem mass spectrometry (IMS-MS/MS) is applied to analysis of human glycourinome to obtain carbohydrate pattern data of congenital disorders of glycosylation patient. Overlapping of the complex carbohydrate mass range landscape has been highly reduced upon IMS-MS procedure, allowing more efficient identification by mapping and sequencing of glycan precursor ions, following their separation by mobility, according to difference in drift time through the traveling wave IMS cell. Intact and truncated N-and Oglycan structures modified by sialylation and fucosylation were identified according to their drift time separated molecular ions and submitted to fragmentation in a narrow mass window. IMS CID MS/MS Analysis The fragmentation spectra generated from the IMS separated precursor ions contain series of fragment ions maintaining the same mobility as their parent ions, and the assignment accuracy can be significantly enhanced. Conclusion According to the specific fragment ion patterns, carbohydrate epitopes described to be involved in pathological processes were assigned. A high potential of this glycomics-based strategy for clinical applications can be presented.
Introduction
Congenital disorders of glycosylation (CDG) are a large family of genetic diseases resulting from defects in the synthesis of glycans and in the attachment of glycans to lipids and proteins. These disorders cause a wide range of clinically relevant human diseases with different, sometimes diffuse, clinical pictures. There are currently 12 defined N-, seven O-and three N-and O-glycosylation defects due to defects in proteins with glycosyltransferase or transport function already identified [1] . For a growing group of patients with unidentified defects, but typical and atypical clinical presentations in CDG, there is a high need for an increase in the speed and accuracy of diagnostics in order to design rational therapeutic suggestions in as short a time span as possible.
The alteration of glycan patterns related to CDG defects is reflected in the patients' serum, which can be analyzed for glycosylation patterns of glycoproteins, according to proteomics-based protocols [2] . However, urine as a rich source of metabolic structures renders an excellent opportunity for noninvasive sample diagnostics. Carbohydrate patterns of CDG patients' urine were investigated by us using distinct glycomics-based strategies to explore the feasibility of protocols and their potential for unique structure discovery and clinical applications [3] [4] [5] [6] . Components of these highly complex mixtures depict different levels of modifications by sialylation and fucosylation. A high number of intact and truncated N-and O-glycan structures were revealed by high resolution mass spectromdatabases [4] . Using a novel approach of ion mobility mass spectrometry (IMS-MS), overlapping of the carbohydrate mass range landscape was shown to be highly reduced, allowing development of strategies for more efficient identification by sequencing the glycan precursor ions, following their separation by their mobility, or drift time, through the traveling wave IMS cell [3] . The fragmentation data obtained clearly demonstrate that carbohydrate epitopes can be de novo identified by this type of bioanalysis rendering an efficient novel tool for glycomics to be introduced to the CDG research and be applied to clinical samples. In the following investigation, monosialylated glycoforms from urine and their terminal epitopes were identified by IMS and automatic data assignment to be correlated with those described in carbohydrate databases for comparison of their possible function.
Materials and Methods

Materials and Sample Preparation
Materials Methanol was obtained from Merck (Darmstadt, Germany) and used without further purification. Graphitized carbon powder for the graphitized carbon cartridge preparation was collected by dismantling commercially available Active Charcoal MicroTip Columns 25-100 µl (Harvard Apparatus Inc). AG50 (H + ) resin was purchased from Bio-Rad (Richmond, CA, USA). Distilled and deionized water (Mili-Q water systems Millipore, Bedford, MA, USA) was used for the preparation of the sample solutions.
CDG urine sample The sample investigated in this study was a native glycoconjugate mixture from the urine of patient K.L. suffering from symptoms assigned to the congenital disorder of glycosylation (CDG). For isolation of components, the patient's urine was filtered and submitted to a first gel filtration chromatography step on Biogel P2 followed by several chromatography stages as described previously [4, 5] . The fraction M3 from the patient K.L. was used in the present study.
Desalting of glycoconjugate mixtures Prior to analysis by mass spectrometry, the fraction M3 containing a mixture of glycoconjugates was purified by homemade graphitized carbon cartridges as described previously [7] and desalted by AG50 (H + ) resin.
Mass spectrometry All measurements were performed on a Synapt high-definition mass spectrometry (HDMS) system (Waters, Manchester, UK). The Synapt HDMS is a hybrid quadrupole-triwave IMS-oa-TOF device. Gas-phase ions were generated by nano-electrospray ionization in the negative ion mode, passed through a quadrupole into the triwave cell where the ions were separated according to their mobility, and finally transferred to the oa-TOF mass analyzer [3] . Ion source conditions were optimized to minimize in-source fragmentation. DriftScope™ Mobility Environment software was used for ion mobility data visualization and manipulation. Instrumental control and mass spectra acquisition were operated by Waters MassLynx 4.1 software. Collision-induced dissociation (CID) structural analysis of selected ionic species was performed by transfer T-Wave fragmentation [3] . The fragmentation pattern of sequenced glycoconjugates was assigned according to nomenclature introduced by Domon and Costello [8] .
Data interpretation The computer algorithm for mass spectrometry data interpretation was developed by using Borland Delphi 7 for Windows (Borland) [3] . All computational assignments have been performed within the mass accuracy range of 0-25 ppm.
Glycan database Consortium for Functional Glycomics (http://www.functionalglycomics.org, 2008) and Glycosuite DB (https://tmat.proteomesystems.com/glycosuite, 2004) glycan databases has been used for correlation with proposed compositions by searching of structural information, such as the type and the number of monosaccharide building blocks. The list of previously described oligosaccharide structures related to the imported composition was generated as the output, providing information about the sample source, methods of structural elucidation, and the corresponding references.
Results
IMS-MS Glycoscreening of the KLM3 CDG Sample
Mapping and sequencing of monosialylated free and amino acid-linked glycans in the urine of the CDG patient K.L. has been probed in the fraction KLM3 to identify the type of glycans involved, their branching patterns, and sialylation attachment. Analyzed in the negative ion MS mode using a nanoESI oa-TOF mass spectrometer more than 100 singly, doubly, and triply charged ions has been observed ( Fig. 1) . Three ubiquitous singly charged ion species at m/z 632.21, 673.22, and 876.30 assigned previously to NeuAcHex 2 , NeuAcHexHexNAc, and NeuAcHexHexNAc 2 , respectively, were present at high abundance 40-100%, but the majority of the ionic species, with highly over-lapping isotopic envelopes, were at or below 15%, substantially hindering the tandem MS identification by mapping and sequencing. As already reported, the introduction of IMS as an additional dimension prior to mass analysis allows effective separation of molecular ions in the gas phase according to their charge, shape, and size [3] . Briefly, the ions are separated by their mobility through the dense gas-filled traveling wave and, subsequently, mass analyzed by the oa-TOF. Plotting the ions drift time versus their m/z values, it can be observed that the signal is distributed into three distinct nested areas, A, B, and C, based upon their m/z and drift time relationship. These nested sets correspond to the singly, doubly, and triply charge ions, respectively ( Fig. 1, inset) . Selection of these regions and maintaining their m/z and drift times produce mass spectra containing predominantly singly, doubly, and triply charged ion populations. These ions previously overlapped in the TOF MS acquisition are now separated and localized into the regions A, B, and C (Fig. 2 ). The ions with the signalto-noise ratio significant for the determination of isotopic distribution are selected and submitted for automated compositional analysis calculation.
The singly charged ion population obtained by selecting region A (Fig. 1a) exposed the presence of at least 62 distinct ionic species, mostly below 15% abundance. Close inspection of the mass spectrum acquired upon IMS separation revealed a significant improvement in the signal-to-noise ratio, as illustrated for the mass range 1500-2000 Da. The data that acquired overall mobility drift times show only three ions at m/z 1565.57, 1727.60, and 1862.88 ( Fig. 1) , where in the same m/z range of the singly charged spectrum acquired from region A, six additional species at m/z 1548. , respectively and proposed to represent free N-glycans without Asn attachment at the reducing end. Computational analysis of all singly charged species in the region A ion population allowed the compositions of~67% of the selected ions to be accomplished. The majority of the species were proposed to represent free oligosaccharides, except 11 ionic species identified by calculation as O-glycans linked either to Ser, Thr, ThrPro, or SerThr (Table 1) .
All doubly charged ions obtained by averaging over region B were low abundant at the level of relative intensity below~12% (Fig. 2b) . According to the compositional analysis, 15 species out of 58 were assigned to free oligosaccharides ( , respectively. In the doubly charged pool, the ions detected in the abundance range of 8-12% at m/z 469.15, 624.26, 930.89, and 1139.94 could not be assigned to any glycoconjugate structures; but, according to their CID MS/MS data, they could be assigned as collagen peptides containing a common Gly-Leu/Ile-Pro repeat (data not shown).
The data from region C produced 18 triply charged species with distinct isotopic distribution that were utilized for compositional analysis (Fig. 2c) Table 1 ). The most intensive triply charged ions detected at m/z 759.66 below 2% abundance were assigned to a collagen peptide with Gly-Leu/Ile-Pro repeat (data not shown).
Thus, in total 138 ionic species with distinct isotopic distribution have been detected by IMS oa-TOF MS approach, and 47 singly and multiply charged species that previously overlapped became well separated using this approach. , respectively, the isotopic pattern of the doubly charged ions is obscured by that of the singly charged one (Fig. 3a) , obstructing both the determination of the monoisotopic m/z value and selection of the appropriate ion selection for fragmentation. Upon separation of the overlapping precursor ions by ion mobility, CID fragmentation using a transfer traveling wave gas cell, which is located after the IMS gas cell, generates distinct sets of fragments, as illustrated for ions at m/z 1200.42 and 1199.93 ( Fig. 3b and c) . The CID fragmentation of these IMS separated precursor ions generates series of fragment ions maintaining the same mobility as their parent ions (Fig. 3d) . These distinct drift time areas can be used to generate individual chromatograms and, subsequently, mass spectra (A and B, respectively), as shown in Fig. 3e . The fragmentation spectrum representing the glycan sequence of the singly charged precursor ions at m/z 1200.42 assigned to [NeuAcHex 3 HexNAc 2 -H] − obtained from drift time region A (Fig. 3e) is presented in Fig. 4 . According to the evidence of the 0,2 A 6 cross-ring fragment ions at m/z 1099.36, the free HexNAc residue at the reducing end can be proposed [5] . Y 2 , B 4 , and C 4 at m/z 364.13, 382. 14, 817.27, and 835.28, respectively, as well as the rules of glycan assembly, the potential structural candidate was proposed as a truncated sialylated N-glycan NeuAc(α2-6)Gal(β1-4) GlcNAc(β1-2)Man(α1-3/6)Man(β1-4)GlcNAc with only one antenna, where the α2-6 linkage between NeuAc and Gal was proposed according to the diagnostic 0,4 A 2 -CO 2 cross-ring fragment being present at m/z 306.12 [9] . Searching the glycan database (http://www.functionalgly comics.org, 2008; https://tmat.proteomesystems.com/glyco suite, 2004) allowed correlation of the proposed structure with the one previously found in the urine of a patient suffering from infantile sialidosis, type II (dysmorphic) [10, 11] . On the other hand, a number of ions which cannot originate from the proposed structure, such as NeuAcHexHexNAc 2 at m/z 876. 35 or NeuAcHex 2 at m/z 632.21, were also found in the spectrum, indicating the existence of an additional structural isomer with the same composition.
The fragmentation pattern of the doubly charged precursor at m/z 1199.93 separated by IMS and obtained by selecting the data shown in region B (Fig. 3e) can be assigned to [NeuAcdHexHex 7 HexNAc 4 -2H] 2− (Fig. 5a) . Inspection of the MS/MS spectrum revealed the presence of fragment ions corresponding to NeuAc(-H 2 O) at m/z 290.10, NeuAcHex at m/z 470.17, and NeuAcHexHex NAc at m/z 673.26. Besides the NeuAcLacNAc antennae terminal, a NeuAcLe a/x antennae structure was present according to the presence of the fragment ion at m/z 819.35. Thus, taking into account the biosynthetic rules of N-glycan antennae assembly as well as the evidence of the existence of truncated glycans in the urine, the structure of this species has been proposed, as summarized in Fig. 5b . (Fig. 5b ). Ions at m/z 1143.54 assigned to NeuAcdHexHex 2 HexNAc can be considered as "D+ H 2 O" type fragment of the structural isomer, where the NeuAcLe a/x antennae is distributed at Man6 of the Nglycan core region (Structure C, Fig. 5b ). Among the proposed structures depicted, only the structure A (Fig. 5b) , supported by the presence of C 4a at m/z 1200.46 has been found in the glycan database with a nonspecified source of origin (http://www.functionalglycomics.org, 2008).
The doubly charged precursor ions at m/z 1055.85 assigned to [NeuAcdHexHex 5 HexNAc 4 -H+Cl] 2− represent another example of sialylated and fucosylated oligosaccharide found in the urine of CDG patient. To obtain a distinct series of fragment ions related only to the doubly charged precursors, IMS T-Wave transfer fragmentation analysis has been performed, and the spectrum acquired over the drift time range from 4.0 to 7.5 ms of the TIC chromatogram (Fig. 6a, inset) . According to biosynthetic rules of glycan assembly and taking into account the ratio of monosaccharide units in the proposed composition, potential structural candidates could be proposed as monosialylated N-glycans with one peripheral or one core fucosylation. The presence of a NeuAcLacNAc antenna has been monitored by the diagnostic fragment ions assigned to NeuAcHexHexNAc detected at m/z 673.27. Fragment ions detected at m/z 819.29 and assigned to NeuAcHexHexNAc indicate a potential NeuAcLe a/x antennae structure, supporting the assumption of peripheral fucosylation. Thus, several structural isomers or isobars could be related to the precursor ions (Fig. 6b) . The presence of diagnostic C 4 and "D" type fragment ions [12] allows to determine the distribution of antennae at the pentasaccharide core of potential structural candidates. Fragment ions at m/z 688.23 and 835.28 assigned to Hex 2 HexNAc and NeuAcHex 2 HexNAc has been considered as "D" and C 4a , respectively, of the monosialylated biantennary N-glycan with core Fuc, where NeuAcLacNAc antenna is attached to Man3 of the core region (Structure A, Fig. 6b ). The attachment of Neu AcLacNAc antenna at Man6 of the core region has been specified by the presence of "D+H 2 O" and C 4b fragment ions at m/z 997.34 and 544.19, respectively (Structure B, Fig. 6b ). On the other hand, fragment ions at m/z 544.19 can also be originated as C 4b from the Structure C (Fig. 6b) , supported by "D" and "D+H 2 O" at m/z 1125.39 and 1143.39, respectively. The fourth structural candidate, isobaric with previous ones, could be proposed and assigned according to glycan biosynthesis rules to a hybrid type monosialylated N-glycan (Structure D, Fig. 6b ). C 4a fragment ions detected at m/z 1184.42 and assigned to NeuAcdHexHex 2 Hex 2 support this assumption. A correlation of the Structure A with that previously discovered in the urine of a male donor by monosaccharide analysis and 1 H NMR [13] has been done by glycan database search (http://www.functionalglycomics.org, 2008).
Thus, according to the analysis performed in this study, the present status of the KLM3 sample composition reveals 30 proposed structures which were found to be associated with detected ionic species. Upon classification of these 30 glycoconjugate structures, the expression of SiaLe a/x and Sialyl T terminal epitopes in both N-and O-linked glycan components could be postulated (Table 2 ). These epitopes have been previously observed in malignant tissues in different organs of human bodies, where glycosylation changes caused by cancer and/or inflammation diseases are the probable cause for their overexpression [14] .
Since the significantly increased degree of core fucosylation of biantennary N-glycans as compared to normal has been reported in all so far known subtypes of CDG I [15] , the validation of fucosylated oligosaccharides in the urine of CDG patient represents a potential direction for biomarker search.
Conclusions
Using the novel approach of ion mobility, separation coupled with tandem mass spectrometry intact and truncated N-and O-glycan structures from CDG patients' urine can be de novo identified by mapping and sequencing. By automatic assignment, the composition of single species from the IMS-separated spectra, with reduced complexity, were shown to be accessible for structure correlations to those in databases. Through the use of IMS, the overlapping carbohydrate m/z landscape was highly reduced in given window, allowing the development of a highly efficient identification procedure by sequencing precursor ions, using transfer CID fragmentation after separation by IMS. Combining it with a previously proposed automated calculation procedure provides an efficient novel tool for glycomics to be introduced, and this can readily be applied to CDG research and clinical samples. Accordingly, different levels of sialylation and fucosylation can be analyzed and assigned to truncated and untruncated glycan structures containing possible clinically relevant epitopes.
